Top Two Of The Day: Myriad Genetics, Inc. (NASDAQ:MYGN), Cboe Global Markets, Inc. (NASDAQ:CBOE)

Myriad Genetics, Inc. (NASDAQ:MYGN)

Myriad Genetics, Inc. (NASDAQ:MYGN) closed at $12.74 on the last trading session with an increase of 0.63%, whereas, it previously closed at $12.66. The company has a market capitalization of $925.82 Million. The company traded shares of 431202 on the trading day while its three month average volume stands at 823.06 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Myriad Genetics, Inc. (NASDAQ:MYGN) produced diluted EPS of -2.68. The EPS estimate for next year as estimated by analysts is at 0.37 while EPS for next quarter is estimated at -0.29. Earnings per Share growth for this year is reported at -100, while the analysts estimated the EPS growth for next year at 0.37% and Earnings growth for next 5 years stands at 8.1% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -35.1%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Myriad Genetics, Inc. (NASDAQ:MYGN) is at 0 while the forward p/e is at 34.62. The P/S or Price to Sales ratio of Myriad Genetics, Inc. (NASDAQ:MYGN) stands at 1.45 and Price to Book or P/B for the most recent quarter stands at 1.03. The Price to Free Cash Flow ratio or P/FCF is reported at 18.33. The quick ratio and the current ratio of Myriad Genetics, Inc. (NASDAQ:MYGN) are reported at 2.1 and 2.3 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Myriad Genetics, Inc. (NASDAQ:MYGN) stands at -13.3, -19.8 and -18.2 respectively

The trailing twelve month Revenue of Myriad Genetics, Inc. (NASDAQ:MYGN) is reported at 638.6 Million with income of -199500000. The outstanding shares of Myriad Genetics, Inc. (NASDAQ:MYGN) are 74.6 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is decreased -1.08 in the last six months. The insider ownership for the shares of Myriad Genetics, Inc. (NASDAQ:MYGN) is ticked at 1.6%, the figure is plummeted -0.24% in the last six months.

Some other important financial aspects to be discussed here for Myriad Genetics, Inc. (NASDAQ:MYGN) is the Mean Target Price estimated by the analysts which stands at 15.86. The 52 week high of Myriad Genetics, Inc. (NASDAQ:MYGN) is placed at 35.29 and 52 week low is standing at 9.24.

Performance wise the shares of Myriad Genetics, Inc. (NASDAQ:MYGN) rose up 0.63% for the week, it also fell -8.48% for the monthly performance, while for the quarter it went down 12.35%. The shares decrease -10.97% for the half year and plummeted for the Year-To-Date performance. The shares of Myriad Genetics, Inc. (NASDAQ:MYGN) shrinked -55.5% for the yearly performance.

Cboe Global Markets, Inc. (NASDAQ:CBOE)

Cboe Global Markets, Inc. (NASDAQ:CBOE) closed at $86.89 on the last trading session with an decrease of -2.37%, whereas, it previously closed at $89. The company has a market capitalization of $9.45 Billion. The company traded shares of 1.33 Million on the trading day while its three month average volume stands at 808.1 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Cboe Global Markets, Inc. (NASDAQ:CBOE) produced diluted EPS of 4.56. The EPS estimate for next year as estimated by analysts is at 5.01 while EPS for next quarter is estimated at 1.08. Earnings per Share growth for this year is reported at 9.7, while the analysts estimated the EPS growth for next year at 5.01% and Earnings growth for next 5 years stands at 2.6% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 21.47%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Cboe Global Markets, Inc. (NASDAQ:CBOE) is at 19.08 while the forward p/e is at 17.34. The P/S or Price to Sales ratio of Cboe Global Markets, Inc. (NASDAQ:CBOE) stands at 3.08 and Price to Book or P/B for the most recent quarter stands at 3.09. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Cboe Global Markets, Inc. (NASDAQ:CBOE) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Cboe Global Markets, Inc. (NASDAQ:CBOE) stands at 0, 0 and 0 respectively

The trailing twelve month Revenue of Cboe Global Markets, Inc. (NASDAQ:CBOE) is reported at 3.06 Billion with income of 0. The outstanding shares of Cboe Global Markets, Inc. (NASDAQ:CBOE) are 108.76 Million. The institutional Ownership of the shares of 85.96 stands at 0.80%, this figure is increased 0 in the last six months. The insider ownership for the shares of Cboe Global Markets, Inc. (NASDAQ:CBOE) is ticked at 0.52%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Cboe Global Markets, Inc. (NASDAQ:CBOE) is the Mean Target Price estimated by the analysts which stands at 97.81. The 52 week high of Cboe Global Markets, Inc. (NASDAQ:CBOE) is placed at 127.93 and 52 week low is standing at 72.01.

Performance wise the shares of Cboe Global Markets, Inc. (NASDAQ:CBOE) fell down -3.28% for the week, it also fell -5.3% for the monthly performance, while for the quarter it went up -6.85%. The shares decrease -2.64% for the half year and plummeted for the Year-To-Date performance. The shares of Cboe Global Markets, Inc. (NASDAQ:CBOE) shrinked -24.38% for the yearly performance.